Tonix Pharma (TNXP) Misses Q2 EPS by 215c
Tonix Pharma (NASDAQ: TNXP) reported Q2 EPS of ($2.68), $2.15 worse than the analyst estimate of ($0.53).
For earnings history and earnings-related data on Tonix Pharma (TNXP) click here.
Tonix Pharma (NASDAQ: TNXP) reported Q2 EPS of ($2.68), $2.15 worse than the analyst estimate of ($0.53).
For earnings history and earnings-related data on Tonix Pharma (TNXP) click here.